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The covalently binding D-glucose analog lO-N-(bromoacetyl)amino-l-decyl-~-D-glucopyranoside (BADG) 
was synthesised and shown to be a high-affinity inhibitor of the renal Na+-D-glucose contransporter. From 
renal brush-border membranes a protein fraction was isolated, in which the concentration of Na+-depen- 
dent phlorizin binding sites per mg protein was enriched 7-fold. In labeling experiments with this protein 
fraction a polypeptide of IU, N 79000 was identified as containing the D-glucose binding site of the renal 
Na+-D-glucose cotransporter. 
Affinity labeling D-Glucose analog D-Glucose binding site 
Brush-border membrane Kidney 
1. INTRODUCTION polypeptide with a molecular weight of about 
Identification and purification of the Na+-D- 
glucose cotransport proteins from kidney or small 
intestine is a difficult task. Whereas purification 
attempts did not yet lead to conclusive information 
concerning the identity of the transporter proteins 
[l--5], experiments with side group specific protein 
reagents and monoclonal antibodies suggest hat a 
72000 may be a component of the Nat-D-glucose 
cotransporter from small intestine [6,7]. Data ob- 
tained with the photoaffinity reagent 4-azido- 
phlorizin [8] suggest hat the 72-kDa polypeptide 
from intestine possibly contains the D-glucose bin- 
ding site. Here, the synthesis of the covalently bin- 
ding D-glucose analog BADG is reported. With 
this reagent he D-glucose binding site of the renal 
Na+-D-glucose cotransporter, which is supposed 
to be structurally different from the D-glucose 
transporter from intestine [9], could be identified 
on a polypeptide of A4, 79000 + 4000. * To whom correspondence should be addressed 
Abbreviations: BADG, lO-N-(bromoacetyl)amino- 
1-decyl-P-D-glucopyranoside; TRA buffer, 10 mM 
triethanolamine-HCI (pH 7.4), 150 mM EDTA di- 
sodium salt, 10% (v/v) glycerol; KC buffer, 20 mM im- 
idazole cyclamate (pH 7.4), 0.1 mM magnesium 
cyclamate, 100 mM potassium cyclamate; NaC buffer, 
20 mM imidazole cyclamate (pH 7.4), 0.1 mM 
magnesium cyclamate, 100 mM sodium cyclamate; 
TLC, thin-layer chromatography; DTT, dithiothreitol 
Nat-D-glucose cotransporter 
2. MATERIALS AND METHODS 
Bromo[l-14C]acetic acid (58 mCi/mmol) was 
supplied by Amersham Buchler (Braunschweig). 
Chemicals used for synthesis were of reagent grade 
and were purchased from Merck (Darmstadt). All 
other chemicals were of highest grade and were ob- 
tained as described earlier [4,5]. 
Published by Ekevier Science Publishers B. V. (Biomedical Division) 
00145793/85/$3.30 0 1985 Federation of European Biochemical Societies 139 
Volume 182, number 1 FEBS LETTERS March 1985 
2.1. Synthesis of 10-N-(bromo[‘4C]acetyl)amino- 
I-decyl-fl-D-glucopyranoside (BADG) 
The synthesis of lo-amino-1-decanol from 
sebacic acid has been previously described [lo- 121. 
The amino group was protected by a benzyloxycar- 
bony1 group as, e.g., described in [13], and the 
product was recrystallized from chloroform-light 
petroleum (40-60°C) and characterized by 
TLC. To form the glycosidic bond 9.86 g 
of 2,3,4,6-tetra-O-acetyl-c~-D-glucopyranosyl bro- 
mide in 30 ml ethanol-free chloroform were added 
to a mixture of the protected aminodecanol 
(8.29 g), silver carbonate (5.54 g), iodine 
(240 mg), molecular sieves 4 A (30 g) and dry 
ethanol-free chloroform (120 ml) and stirred for 1 
day in the dark [14]. The reaction mixture was 
filtered through Celite and the solvent was 
evaporated. The residue was dissolved in 
chloroform/methanol (99/ 1, v/v) and purified on 
a silic acid column which was run with the same 
solvent. The compound was deacetylated in dry 
methanol containing 0.03 N sodium methoxide. 
lo-Benzyloxycarbonylamino- 1 decyl-&D-glucopy- 
ranoside was purified on a silic acid column which 
was performed with methanol/chloroform (85/15, 
v/v). To remove the benzyloxycarbonyl group 1 g 
of the compound was hydrogenolyzed in 20 ml of 
0.14 N HCl in 60% (v/v) methanol containing 
120 mg of palladium on carbon. The resulting 
aminoglycoside was yielded chromatographically 
pure by lyophilization of the filtered reaction mix- 
ture and was characterized by TLC and paper elec- 
trophoresis. To form the bromoacetyl derivative 
2.5 mg of bromo[‘4C]acetic acid were converted to 
the acid chloride by 12 h incubation in 1 ml thionyl 
chloride at room temperature and the solution was 
evaporated to dryness (below 40°C). Then a solu- 
tion of 50~1 water containing 10 mg of the 
aminoglycoside and 16 mg KHCO, was added to 
the residual syrup and the mixture was incubated 
for 1 h at 0°C. The final product BADG was 
purified by preparative paper electrophoresis, 
which was performed on Whatman 3MM paper in 
0.1 M acetic acid-KOH (pH 4), and was squeezed 
out from the paper. 
2.2. Partial purification of the Na’-D-glucose 
cotransporter 
The labeling experiments were performed with a 
membrane protein fraction, in which the number 
140 
of Naf-dependent high affinity phlorizin binding 
sites per mg protein was 7-fold enriched compared 
with intact brush-border membranes. Brush- 
border membranes were isolated from proximal 
tubules of the outer cortex of pig kidneys [4] and 
were solubilized with deoxycholate in the presence 
of 1 M D-glucose and thereafter centrifuged as 
described in solubilization procedure c in [5]. 
When in the supernatant he protein and deox- 
ycholate concentration was reduced to 1.5 mg/ml 
and 0. 1 %, respectively, and D-glucose was partial- 
ly removed by 3 h dialysis against glucose-free buf- 
fer some of the solubilized proteins precipitated. 
The aggregated mixed micelles were separated by 
centrifugation and washed with 20 mM imidazole- 
HCl (pH 7.4), 0.1 mM magnesium cyclamate, 
100 mM potassium cyclamate (KC buffer). To 
measure the number of phlorizin binding sites the 
sample was incubated for 5 min at 37°C with dif- 
ferent concentrations of radioactively labeled 
phlorizin in the presence of 20 mM imidazole 
cyclamate (pH 7.4), 0.1 mM magnesium cyclamate 
plus 100 mM potassium cyclamate (KC buffer) or 
100 mM sodium cyclamate (NaC buffer) and then 
washed by Millipore filtration with ice-cold KC or 
NaC buffer. The number of Na+-dependent 
phlorizin binding sites in the aggregated mixed 
micelles was 400-600 pmol per mg protein. 
2.3. Labeling experiments 
Labeling was performed without (i) and with (ii) 
dithiothreitol (DTT) pretreatment. (i) Aggregated 
mixed micelles were incubated for 2 h at 37°C in 
KC or NaC buffer containing 14 ,uM radioactively 
labeled BADG. Parallel experiments were per- 
formed in the absence of glucose or in the presence 
of 85 mM D-glucose, 85 mM L-glucose, 85 mM ,& 
methyl glucoside or 85pM phlorizin. (ii) Ag- 
gregated mixed micelles were incubated for 10 min 
at 37°C in NaC buffer containing 3 mM DTT plus 
85 mM L-glucose or plus 85 mM D-glucose. Then 
the sample was 11 times diluted with ice-cold KC 
buffer and centrifuged for 30 min at 80000 x g. 
Thereafter the pellets were incubated for 2 h at 
37°C in NaC buffer containing 85 mM L-glucose 
plus 14 FM radioactively labeled BADG. 
After incubation with BADG the samples were 
diluted lo-fold with 100 mM cysteine (OOC) and 
spun down by centrifugation at 80000 x g. For gel 
electrophoresis the pellets were resuspended in 
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63 mM Tris-HCl (pH 6.8), 8 M urea, 10% 
glycerol, 2% SDS, 5% ~-mercaptoethanol and for 
10 min incubated at 100°C. 5OO~g portions of 
protein were applied on top of large diameter 10% 
polyacrylamide rod gels and electrophoresis was 
performed according to Laemmi [ 151. The gels 
were fixed with trichloroacetic acid, washed with 
ethanol/acetic acid/H20 (25/S/67, v/v), stained 
with Coomassie brilliant blue R 250, scanned at 
600 nm and cut into 2 mm slices. The slices were 
digested and counted for radioactivity. 
3. RESULTS 
When the reversible interaction of BADG with 
the Na+-D-glucose cotransporter was analysed by 
measuring the inhibition of initial Na+ gradient- 
dependent D-glucose uptake rates in pro- 
teoliposomes, which were formed as recently 
described (see LipIIc in [S]), a Ki of 30,uM was 
estimated for competitive inhibition by BADG. 
To covalently label the D-glucose binding site of 
the renal Na+-D-glucose cotransporter two 
strategies were employed. (i) On the one hand, we 
tried to protect the D-glucose binding site from 
covalent BADG labeling by addition of D-glucose 
or phlorizin. (ii) On the other hand, we tried to 
cleave or protect cleavage of a disulfide bridge, 
which has been demonstrated to be essential for 
substrate binding of the renal Na+-D-glucose 
cotr~sporter 116,171, and to covalently label the 
D-glucose binding site thereafter. 
(i) Aggregated mixed micelles, which were 
prepared as described in section 2, were incubated 
for 2 h at 37°C with BADG in the presence of Na+ 
or K+. To demonstrate protection of the D-glucose 
binding site the incubation was performed in the 
absence of glucose, in the presence of 85 mM L- 
glucose, 85 mM D-glucose, 85 mM &methyl 
glucoside or 8.5 FM phlorizin. From fig.1 it can be 
seen that some of the proteins were preferentially 
labeled. Labeling of proteins was identical if it was 
performed in the absence of glucose or in the 
presence of 8.5 mM L-glucose (not shown). In 
fig. 1 b BADG labeling in the presence of 85 mM L- 
glucose or 85 mM D-glucose is shown. In fig. Ic the 
D-glucose protectable labeling is demonstrated. 
Although high unspecific labeling of some proteins 
was observed in the presence of D-glucose, D- 
glucose protection of a 79 + 4 kDa polypeptide 
205k 9Lk 67k 43k 30k 
. 
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Fig.1. Covalent labeling of renal brush-border 
membrane proteins with BADG in the presence of L- or 
D-glucose. Proteinl-lipid aggregates were isolated from 
renal brush-border membranes and labeled with BADG 
in the presence of Na+ and either L- or D-glucose. 
Formation of protein-lipid aggregates, BADG labeling 
and SDS-polyacrylamide gel electrophoresis are 
described in section 2. (a) A densitogram of protein-lipid 
aggregates, which have been separated by SDS-gel 
electrophoresis, is shown; (b) the radioactivity 
distribution after BADG labeling in the presence of L- 
glucose (solid line) or D-glucose (broken line) is 
demonstrated; (c) the difference between the IabeIing in 
the presence of D- and L-glucose is shown. The lines in 
(b) and (c), which are connecting 54 measuring points, 
are fitted by computer. In (a) the positions of the marker 
proteins myosin (205 kDa), phosphorylase b (94 kDa), 
bovine serum albumin (67 kDa), ovalbumin (43 kDa) 
and carboanhydrase (30 kDa) are indicated. 
could be reproducibly demonstrated. Some D- 
glucose protection was observed in the high 
molecular mass region and it was found that the 
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absence of 85 pM phlorizin are shown. 
Fig.2. Na+-dependency for phloririn protection of a 
79 kDa polypeptide from BADC labeling. Protein-lipid 
aggregates, prepared as in fig. 1, were incubated with 
radioactively labeled BADG in the presence of Na+ (a) 
or K+ (b) as described in section 2. In the graphs the 
differences between BADG labeling in the presence and 
labeling of a 45 kDa polypeptide was slightly in- 
creased in the presence of D-glucose (see section 4). 
In fig.2 the phlorizin protectable BADG labeling 
measured at pH 7.4 in the presence and absence of 
Na+ is shown. Since significant protection of the 
79 kDa polypeptide was observed only in the 
presence of Na+ it has been demonstrated that the 
BADG labeling was reduced if phlorizin bound to 
the D-glucose binding site. The phlorizin protec- 
tion of the 79 kDa polypeptide in the presence of 
Na+ was also observed at pH 6 but was not found 
at pH 9.5 (not shown). 
(ii) When membrane proteins were treated for 
10 min at 37°C with 3 mM DTT and then labeled 
with BADG it was found that labeling of most pro- 
teins was increased by a factor of 1.8-2.2 (fig.3). 
Only in the 79 kDa polypeptide and in the high 
molecular mass region of the gel was labeling in- 
creased to a higher extent. The selective increase in 
the labeling of the 79 kDa polypeptide by the 
pretreatment with DTT was more pronounced if 
control labeling without DTT pretreatment was 
performed in the presence of 85 mM D-glucose 
(compare open and closed symbols in fig.3). These 
Fig.3. Selective increase of BADG labeling of a 79 kDa 
polypeptide if disulfides are reduced in the presence of 
glucose f*). 
D-glucose. In the presence of D-glucose and Na+ 
protein-lipid aggregates were incubated with DTT as 
described in section 2. After washing the samples and in 
parallel also control samples, which had not been treated 
with DTT, were incubated with radioactively labeled 
BADG (in the presence of Na+ and L-glucose). Control 
labeling was also performed in the presence of D- 
glucose. In the graph ratios of radioactivity are shown, 
in which protein labeling after reduction with DTT is 
refated to the protein labeling without DTT 
pretreatment, performed in the presence of L- (0) or D- 
data strongly suggest hat BADG does not act as 
an unspecific SH-group modifying reagent but in- 
teracts selectively at the D-glucose binding site of 
the Na+-D-glucose cotransporter. 
In fig.4 the difference in BADC labeling of 
membrane proteins is shown, which had been 
pretreated with 3 mM DTT in the presence of 
either L-glucose or D-glucose. It can be seen that 
due to the presence of D-glucose during DTT 
pretreatment specific covalently BADC labeling of 
the 79 kDa polypeptide was observed. Findings of 
Turner and George 116,171 show that at least two 
disulfide bridges are cleaved at the D-glucose bind- 
ing site by DTT and that one of these is essential 
for substrate binding and can be protected by addi- 
tion of substrate. Here, the essential disulfide 
bridge has been cleaved by DTT (presence of L- 
glucose) or has been partially protected by D- 
glucose. Selective labeling of the D-glucose binding 
site by the D-glucose analog BADG was possible in 
a higher extent if the DTT pretreatment was per- 
formed in the presence of D-glucose and more D- 
glucose binding sites remained intact. The finding 
that BADG labeling at the 79 kDa polypeptide was 
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Fig.4. Specific labeling of a 79 kDa polypeptide by 
BADG if during reduction of disulfide bonds the D- 
glucose binding site of the Na+-D-glucose cotransporter 
was protected. Protein-lipid aggregates were in the 
presence of Na+ plus L- or D-glucose incubated with 
DTT. After washing the samples were incubated with 
radioactively labeled BADG (in the presence of Na+ and 
L-glucose). In the graph the difference of BADG 
labeling obtained after dithiothreitol pretreatment in the 
presence of either D- or L-glucose is shown. 
increased under a condition in which less SH- 
groups are generated but more D-glucose binding 
sites remained intact (presence of D-glucose during 
dithiothreitol pretreatment) is another indication 
that BADG labeling is a specific reaction at the D- 
glucose binding site of the Naf-D-glucose 
cotransporter. 
4. DISCUSSION 
Similar to other aliphatic glucosides [18] BADG 
has a higher affinity to the glucose transporter 
than D-glucose. At variance to photoaffinity Iabel- 
ing reagents [8] BADG reacts with nucleophiles, 
especially with SH but also with imidazole and 
amino groups, and is suitable to detect alterations 
in accessibility or occurrence of these groups. The 
degree of labeling is supposed to be higher with 
bromoacetyl derivatives than with photoaffinity 
reagents. In the case of BADG successful labeling 
may have been achieved since the bromacetyl 
group is in a mobile way linked to the reversibly 
binding D-glucose moiety of the molecule. With 
BADG a broad 75-83 kDa polypeptide band 
could be identified to carry the D-glucose binding 
site of the renal Na+-D-glucose cotransporter. 
Firstly, labeling with BADG could be protected 
with D-glucose, @-methylglucoside or phlorizin. 
This protection was Na+ and pH dependent. 
Secondly, this band was shown to react specifically 
with BADG, if during the reduction of disulfide 
bonds a disulfide bridge essential for substrate 
binding was protected by addition of D-glucose 
and Na+. This appears to be specific for the renal 
Na+-D-glucose cotransporter [9]. The fact that the 
identified polypeptide is a rather broad band in the 
gel suggests that it is a glycoprotein. Since in the 
high molecular mass region of the highly loaded 
gels the separation of polypeptides was incomplete 
(see fig.la) the D-glucose or phlorizin protectable 
BADG labeling observed in this region is 
presumably due to the presence of aggregated 
79 kDa polypeptides. In the experiments without 
DTT pretreatment it was found that in the 
presence of D-glucose or phlorizin labeling was in- 
creased at a 45 kDa polypeptide, which has been 
shown by immunological studies to be identical 
with actin (unpublished). This effect could be a 
reproducible artifact, it may however also be ex- 
plained by the hypothesis that actin may be closely 
associated with the transporter, so that D-glucose 
binding could lead to a concerted structural change 
which may result in an increase of the unspecific 
BADG labeling. Target size analysis of 
Na+-dependent phlorizin binding in renal brush- 
border membranes revealed two functional units 
of M, -230000 and 110000 [19,20], suggesting that 
the transporter in the membrane may exist as 
monomer or dimer. Each monomer, which is able 
to bind phlorizin, should contain the 79 kDa 
polypeptide with the D-glucose binding site and 
possibly another -30 kDa subunit [21]. Since for 
the target size of D-glucose uptake in renal brush- 
border membranes an M, of -345000 was 
estimated [20] it may be speculated that the 
transport unit may be even more complex. To 
finally elucidate the molecular structure of the 
Na*-D-glucose cotransporter the 79 kDa polypep- 
tide and the other hypothetical subunits have to be 
purified and functionally reconstituted. 
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